Male Infertility Market 2027 By Test, Treatment Type, Distribution Channel, End User and Geography | The Insight Partners

Male Infertility Market to 2027 - Global Analysis and Forecasts By Test (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm Penetration Assay, Others); Treatment Type (Assisted Reproductive Technology and Varicocele Surgery, Medication); Distribution Channel (Hospitals Pharmacies, Pharmacies and Drug Stores, Online Pharmacies); End User (Hospitals and Clinics, Fertility Centers, Research Institutes, Other End Users) and Geography

Report Code: TIPRE00007061 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Male infertility or sterility is a medical condition where the male is unable to produce or release sperm. Male infertility is due to abnormal sperm function, low sperm production, or blockages that stop the delivery of sperm. Chronic illnesses, injuries, and sedentary lifestyles and other factors play a major role in causing male infertility.

MARKET DYNAMICS

The male infertility market is anticipated to grow in the forecast, owing to factors such as increasing infertility rate, rising adoption of assisted reproductive technologies (ART), and a shift towards sedentary lifestyle across the globe. Furthermore, the rising aging population, growing obesity, and other lifestyle-associated diseases are likely to pose significant opportunities for the market to grow.

MARKET SCOPE

The "Global Male infertility market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of male infertility market with detailed market segmentation by test, treatment type, distribution channel, end user and geography. The global Male infertility market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Male infertility market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global male infertility market is segmented on the basis of test, treatment type, distribution channel, end user. Based on test the market is segmented into DNA fragmentation technique, oxidative stress analysis, microscopic examination, sperm agglutination, computer assisted semen analysis, sperm penetration assay, and others. Based on treatment type the market is segmented assisted reproductive technology and varicocele surgery, and medication. The distribution channel is segmented into hospitals pharmacies, pharmacies and drug stores, online pharmacies. The end user market is segmented into hospitals and clinics, fertility centers, research institutes, and other end users.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Male infertility market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The male infertility market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting male infertility market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Male infertility market in these regions.

MARKET PLAYERS


The reports cover key developments in the male infertility market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from male infertility market are anticipated to lucrative growth opportunities in the future with the rising demand for male infertility market in the global market. Below mentioned is the list of few companies engaged in the male infertility market.

The report also includes the profiles of male infertility market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  EMD Serono, Inc.
  •  Endo International plc
  •  Sanofi
  •  Bayer Group
  •  SCSA Diagnostics
  •  Andrology Solutions
  •  Halotech DNA SL
  •  Intas Pharmaceuticals Ltd.
  •  Vitrolife
  •  Cadila Pharmaceuticals Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Male Infertility Market - By Test
1.3.2 Male Infertility Market - By Treatment Type
1.3.3 Male Infertility Market - By Distribution Channel
1.3.4 Male Infertility Market - By End User
1.3.5 Male Infertility Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. MALE INFERTILITY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. MALE INFERTILITY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. MALE INFERTILITY MARKET - GLOBAL MARKET ANALYSIS
6.1. MALE INFERTILITY - GLOBAL MARKET OVERVIEW
6.2. MALE INFERTILITY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. MALE INFERTILITY MARKET - REVENUE AND FORECASTS TO 2027 - TEST
7.1. OVERVIEW
7.2. TEST MARKET FORECASTS AND ANALYSIS
7.3. DNA FRAGMENTATION TECHNIQUE
7.3.1. Overview
7.3.2. DNA Fragmentation Technique Market Forecast and Analysis
7.4. OXIDATIVE STRESS ANALYSIS
7.4.1. Overview
7.4.2. Oxidative Stress Analysis Market Forecast and Analysis
7.5. MICROSCOPIC EXAMINATION
7.5.1. Overview
7.5.2. Microscopic Examination Market Forecast and Analysis
7.6. SPERM AGGLUTINATION
7.6.1. Overview
7.6.2. Sperm Agglutination Market Forecast and Analysis
7.7. COMPUTER ASSISTED SEMEN ANALYSIS
7.7.1. Overview
7.7.2. Computer Assisted Semen Analysis Market Forecast and Analysis
7.8. SPERM PENETRATION ASSAY
7.8.1. Overview
7.8.2. Sperm Penetration Assay Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis

8. MALE INFERTILITY MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY
8.3.1. Overview
8.3.2. Assisted Reproductive Technology and Varicocele Surgery Market Forecast and Analysis
8.4. MEDICATION
8.4.1. Overview
8.4.2. Medication Market Forecast and Analysis

9. MALE INFERTILITY MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS PHARMACIES
9.3.1. Overview
9.3.2. Hospitals Pharmacies Market Forecast and Analysis
9.4. PHARMACIES AND DRUG STORES
9.4.1. Overview
9.4.2. Pharmacies and Drug Stores Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis

10. MALE INFERTILITY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. FERTILITY CENTERS
10.4.1. Overview
10.4.2. Fertility Centers Market Forecast and Analysis
10.5. RESEARCH INSTITUTES
10.5.1. Overview
10.5.2. Research Institutes Market Forecast and Analysis
10.6. OTHER END USERS
10.6.1. Overview
10.6.2. Other End Users Market Forecast and Analysis

11. MALE INFERTILITY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Male Infertility Market Overview
11.1.2 North America Male Infertility Market Forecasts and Analysis
11.1.3 North America Male Infertility Market Forecasts and Analysis - By Test
11.1.4 North America Male Infertility Market Forecasts and Analysis - By Treatment Type
11.1.5 North America Male Infertility Market Forecasts and Analysis - By Distribution Channel
11.1.6 North America Male Infertility Market Forecasts and Analysis - By End User
11.1.7 North America Male Infertility Market Forecasts and Analysis - By Countries
11.1.7.1 United States Male Infertility Market
11.1.7.1.1 United States Male Infertility Market by Test
11.1.7.1.2 United States Male Infertility Market by Treatment Type
11.1.7.1.3 United States Male Infertility Market by Distribution Channel
11.1.7.1.4 United States Male Infertility Market by End User
11.1.7.2 Canada Male Infertility Market
11.1.7.2.1 Canada Male Infertility Market by Test
11.1.7.2.2 Canada Male Infertility Market by Treatment Type
11.1.7.2.3 Canada Male Infertility Market by Distribution Channel
11.1.7.2.4 Canada Male Infertility Market by End User
11.1.7.3 Mexico Male Infertility Market
11.1.7.3.1 Mexico Male Infertility Market by Test
11.1.7.3.2 Mexico Male Infertility Market by Treatment Type
11.1.7.3.3 Mexico Male Infertility Market by Distribution Channel
11.1.7.3.4 Mexico Male Infertility Market by End User
11.2. EUROPE
11.2.1 Europe Male Infertility Market Overview
11.2.2 Europe Male Infertility Market Forecasts and Analysis
11.2.3 Europe Male Infertility Market Forecasts and Analysis - By Test
11.2.4 Europe Male Infertility Market Forecasts and Analysis - By Treatment Type
11.2.5 Europe Male Infertility Market Forecasts and Analysis - By Distribution Channel
11.2.6 Europe Male Infertility Market Forecasts and Analysis - By End User
11.2.7 Europe Male Infertility Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Male Infertility Market
11.2.7.1.1 Germany Male Infertility Market by Test
11.2.7.1.2 Germany Male Infertility Market by Treatment Type
11.2.7.1.3 Germany Male Infertility Market by Distribution Channel
11.2.7.1.4 Germany Male Infertility Market by End User
11.2.7.2 France Male Infertility Market
11.2.7.2.1 France Male Infertility Market by Test
11.2.7.2.2 France Male Infertility Market by Treatment Type
11.2.7.2.3 France Male Infertility Market by Distribution Channel
11.2.7.2.4 France Male Infertility Market by End User
11.2.7.3 Italy Male Infertility Market
11.2.7.3.1 Italy Male Infertility Market by Test
11.2.7.3.2 Italy Male Infertility Market by Treatment Type
11.2.7.3.3 Italy Male Infertility Market by Distribution Channel
11.2.7.3.4 Italy Male Infertility Market by End User
11.2.7.4 Spain Male Infertility Market
11.2.7.4.1 Spain Male Infertility Market by Test
11.2.7.4.2 Spain Male Infertility Market by Treatment Type
11.2.7.4.3 Spain Male Infertility Market by Distribution Channel
11.2.7.4.4 Spain Male Infertility Market by End User
11.2.7.5 United Kingdom Male Infertility Market
11.2.7.5.1 United Kingdom Male Infertility Market by Test
11.2.7.5.2 United Kingdom Male Infertility Market by Treatment Type
11.2.7.5.3 United Kingdom Male Infertility Market by Distribution Channel
11.2.7.5.4 United Kingdom Male Infertility Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Male Infertility Market Overview
11.3.2 Asia-Pacific Male Infertility Market Forecasts and Analysis
11.3.3 Asia-Pacific Male Infertility Market Forecasts and Analysis - By Test
11.3.4 Asia-Pacific Male Infertility Market Forecasts and Analysis - By Treatment Type
11.3.5 Asia-Pacific Male Infertility Market Forecasts and Analysis - By Distribution Channel
11.3.6 Asia-Pacific Male Infertility Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Male Infertility Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Male Infertility Market
11.3.7.1.1 Australia Male Infertility Market by Test
11.3.7.1.2 Australia Male Infertility Market by Treatment Type
11.3.7.1.3 Australia Male Infertility Market by Distribution Channel
11.3.7.1.4 Australia Male Infertility Market by End User
11.3.7.2 China Male Infertility Market
11.3.7.2.1 China Male Infertility Market by Test
11.3.7.2.2 China Male Infertility Market by Treatment Type
11.3.7.2.3 China Male Infertility Market by Distribution Channel
11.3.7.2.4 China Male Infertility Market by End User
11.3.7.3 India Male Infertility Market
11.3.7.3.1 India Male Infertility Market by Test
11.3.7.3.2 India Male Infertility Market by Treatment Type
11.3.7.3.3 India Male Infertility Market by Distribution Channel
11.3.7.3.4 India Male Infertility Market by End User
11.3.7.4 Japan Male Infertility Market
11.3.7.4.1 Japan Male Infertility Market by Test
11.3.7.4.2 Japan Male Infertility Market by Treatment Type
11.3.7.4.3 Japan Male Infertility Market by Distribution Channel
11.3.7.4.4 Japan Male Infertility Market by End User
11.3.7.5 South Korea Male Infertility Market
11.3.7.5.1 South Korea Male Infertility Market by Test
11.3.7.5.2 South Korea Male Infertility Market by Treatment Type
11.3.7.5.3 South Korea Male Infertility Market by Distribution Channel
11.3.7.5.4 South Korea Male Infertility Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Male Infertility Market Overview
11.4.2 Middle East and Africa Male Infertility Market Forecasts and Analysis
11.4.3 Middle East and Africa Male Infertility Market Forecasts and Analysis - By Test
11.4.4 Middle East and Africa Male Infertility Market Forecasts and Analysis - By Treatment Type
11.4.5 Middle East and Africa Male Infertility Market Forecasts and Analysis - By Distribution Channel
11.4.6 Middle East and Africa Male Infertility Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Male Infertility Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Male Infertility Market
11.4.7.1.1 South Africa Male Infertility Market by Test
11.4.7.1.2 South Africa Male Infertility Market by Treatment Type
11.4.7.1.3 South Africa Male Infertility Market by Distribution Channel
11.4.7.1.4 South Africa Male Infertility Market by End User
11.4.7.2 Saudi Arabia Male Infertility Market
11.4.7.2.1 Saudi Arabia Male Infertility Market by Test
11.4.7.2.2 Saudi Arabia Male Infertility Market by Treatment Type
11.4.7.2.3 Saudi Arabia Male Infertility Market by Distribution Channel
11.4.7.2.4 Saudi Arabia Male Infertility Market by End User
11.4.7.3 U.A.E Male Infertility Market
11.4.7.3.1 U.A.E Male Infertility Market by Test
11.4.7.3.2 U.A.E Male Infertility Market by Treatment Type
11.4.7.3.3 U.A.E Male Infertility Market by Distribution Channel
11.4.7.3.4 U.A.E Male Infertility Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Male Infertility Market Overview
11.5.2 South and Central America Male Infertility Market Forecasts and Analysis
11.5.3 South and Central America Male Infertility Market Forecasts and Analysis - By Test
11.5.4 South and Central America Male Infertility Market Forecasts and Analysis - By Treatment Type
11.5.5 South and Central America Male Infertility Market Forecasts and Analysis - By Distribution Channel
11.5.6 South and Central America Male Infertility Market Forecasts and Analysis - By End User
11.5.7 South and Central America Male Infertility Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Male Infertility Market
11.5.7.1.1 Brazil Male Infertility Market by Test
11.5.7.1.2 Brazil Male Infertility Market by Treatment Type
11.5.7.1.3 Brazil Male Infertility Market by Distribution Channel
11.5.7.1.4 Brazil Male Infertility Market by End User
11.5.7.2 Argentina Male Infertility Market
11.5.7.2.1 Argentina Male Infertility Market by Test
11.5.7.2.2 Argentina Male Infertility Market by Treatment Type
11.5.7.2.3 Argentina Male Infertility Market by Distribution Channel
11.5.7.2.4 Argentina Male Infertility Market by End User

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. MALE INFERTILITY MARKET, KEY COMPANY PROFILES
13.1. EMD SERONO, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ENDO INTERNATIONAL PLC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. SANOFI
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BAYER GROUP
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. SCSA DIAGNOSTICS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ANDROLOGY SOLUTIONS
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. HALOTECH DNA SL
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. INTAS PHARMACEUTICALS LTD.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. VITROLIFE
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. CADILA PHARMACEUTICALS LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. EMD Serono, Inc.
2. Endo International plc
3. Sanofi
4. Bayer Group
5. SCSA Diagnostics
6. Andrology Solutions
7. Halotech DNA SL
8. Intas Pharmaceuticals Ltd.
9. Vitrolife
10. Cadila Pharmaceuticals Ltd.